Evaluation of pharmacodynamic (PD) biomarkers in patients with metastatic pancreatic cancer treated with BL-8040, a novel CXCR4 antagonist.

Manuel Hidalgo, Daniel D. Von Hoff, Valeriya Semenisty et al.|Journal of Clinical Oncology|2018

Cited by 0